EUR/USD to consolidate around 1.08-1.09 with upside risks – Danske Bank
EUR/USD holds around 1.08 as Trump imposes auto tariffs and signals lenient reciprocal measures, Danske Bank's FX analyst Jesper Fjärstedt reports.
USD reaction to tariffs remains uncertain
"Yesterday, we outlined enacted and upcoming tariffs, their direct GDP impact, and potential next steps. The USD reaction remains uncertain, with past tariff impacts so far mixed - lower import demand and inflationary effects offset by growth concerns. Aggressive tariffs could fuel risk-off sentiment, but USD upside is not guaranteed if markets focus on US recession risks."
"Near term, we expect EUR/USD to consolidate around 1.08-1.09 with upside risks. Given the uncertainty, we see a wide outcome space and look to sell into potential USD rallies on aggressive tariff announcements, as implementation delays may allow room for negotiation and potential reversals of initial market reactions."
Related Articles
Micron Technology Q4 FY2025 Earnings Preview: Leveraging DRAM Strength and Accelerating HBM Growth
TradingKey - Micron Technology, Inc. (NASDAQ: MU) will report Q4 FY2025 results after the market close on Tuesday, September 23, 2025, with the webcasted conference call scheduled for 4:30 PM EDT. As a leading global supplier of memory chips, including DRAM, NAND flash, and advanced memory like...
Fed Rate Cuts: Will the Russell 2000 Outperform the S&P 500?
TradingKey - On 17 September, the Federal Reserve cut interest rates by 25 basis points, marking the official restart of the rate-cutting cycle. In theory, small-cap stocks, compared to large-cap stocks, benefit more from Fed rate cuts. This is because they are more reliant on external financing...
What Is Worldcoin? Why Did WLD Surge Suddenly, and What’s Next?
Worldcoin is evolving from a “hype token” into a foundational layer for global identity. Its fusion of biometrics, blockchain, and financial inclusion has earned growing recognition from users and institutions. If it can overcome technical hurdles, launch real-world payment use cases, and stabilize
From Ozempic to Wegovy: Growth and Risks Behind Novo Nordisk’s Q2 Performance
TradingKey - Novo Nordisk achieved revenue of $11.67 billion in Q2 of the 2025 fiscal year, a 19% increase year-over-year, but it fell short of market expectations. Growth was primarily driven by strong performance in obesity care and rare diseases.
ASML Q2 FY2025 Earnings Review: Strong Growth and High-NA EUV Breakthrough Shadowed by 2026 Uncertainty
ASML Holding N.V. (NASDAQ: ASML) released its Q2 FY2025 earnings on July 16, 2025, exceeding market expectations with robust net sales and net bookings, though the stock fell around 10% due to cautious guidance for 2026 amid geopolitical uncertainties.
